Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Histogen Inc

HSTO
Current price
0.21 USD 0 USD (0.00%)
Last closed 0.21 USD
ISIN US43358Y2028
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 897 069 USD
Yield for 12 month -34.82 %
1Y
3Y
5Y
10Y
15Y
HSTO
21.11.2021 - 28.11.2021

Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California. Address: 10655 Sorrento Valley Road, San Diego, CA, United States, 92121

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2 USD

P/E ratio

Dividend Yield

Current Year

+19 000 USD

Last Year

+3 769 000 USD

Current Quarter

+5 000 USD

Last Quarter

+5 000 USD

Current Year

Last Year

+3 769 000 USD

Current Quarter

-57 000 USD

Last Quarter

-33 000 USD

Key Figures HSTO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -11 917 000 USD
Operating Margin TTM -70500 %
PE Ratio
Return On Assets TTM -53.81 %
PEG Ratio
Return On Equity TTM -119.89 %
Wall Street Target Price 2 USD
Revenue TTM 19 000 USD
Book Value 1.27 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -1 252 000 USD
Earnings per share -2.81 USD
Diluted Eps TTM -2.81 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics HSTO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HSTO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 03.06.2022
Dividend Date 27.05.2020

Stock Valuation HSTO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.8893
Price Sales TTM 47.2142
Enterprise Value EBITDA 0.199
Price Book MRQ 0.167

Financials HSTO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HSTO

For 52 weeks

0.1 USD 0.55 USD
50 Day MA 0.23 USD
Shares Short Prior Month 40 166
200 Day MA 0.28 USD
Short Ratio 4.25
Shares Short 67 030
Short Percent 1.62 %